Artificial Intelligence Based Cancer Nanomedicine: Diagnostics, Therapeutics and Bioethics

Author(s): Malathi Sampath and Ranjita Misra * .

DOI: 10.2174/9789815050561122010008

Artificial Intelligence-based Nanosensors to Compose the Patient's Cancer Biomarker Profile

Pp: 39-52 (14)

Buy Chapters

* (Excluding Mailing and Handling)

  • * (Excluding Mailing and Handling)

Abstract

SHS investigation development is considered from the geographical and historical viewpoint. 3 stages are described. Within Stage 1 the work was carried out in the Department of the Institute of Chemical Physics in Chernogolovka where the scientific discovery had been made. At Stage 2 the interest to SHS arose in different cities and towns of the former USSR. Within Stage 3 SHS entered the international scene. Now SHS processes and products are being studied in more than 50 countries.

Abstract

To design biomarker diagnostics, unique characteristics of nanotechnology are utilized. For decades, biomarkers have been used in clinical medicine. The use of such high-sensitivity nanosensors will provide patients with an earlier diagnosis of the disease and make major improvements in clinical outcomes. The biomarker profiles taken from tumor samples of patients and the clinical meta data can provide proficient management of cancer patients having comparable molecular subtypes. Thus, artificial intelligence plays a major role in developing advanced diagnostic tools, such as nanosensors, that focus on identifying the complexity of cancer disease diagnosis, thereby emerging as a valuable cancer research outcome in the public domain. This chapter focuses on nanosensors, highlighting their importance for cancer diagnosis applications. 

We recommend

Favorable 70-S: Investigation Branching Arrow

Authors:Bentham Science Books